Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04176562 · ClinicalTrials.gov registry record
Prospective SPINE Registry
A clinical trial of Spinal Fusion and Spinal Stenosis, sponsored by Xtant Medical.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 12
- Study locations
NCT04176562: Recruiting study of Spinal Fusion and Spinal Stenosis, sponsored by Xtant Medical.
NCT04176562 is a study of Spinal Fusion and Spinal Stenosis that is actively recruiting participants, run by Xtant Medical. The registered enrollment target is 5,000 participants, above the 220-participant average among 19 other Spinal Fusion trials with a reported enrollment target (2173% higher). The trial reports 12 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04176562, a study of Spinal Fusion and Spinal Stenosis, is actively recruiting participants, sponsored by Xtant Medical.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 12
- Study locations
Study Summary
This study is a prospective, multi-center, open label registry designed to collect real-world data on performance and safety data on RTI's spine products.
Conditions Studied
Interventions
- DEVICE RTI Spine products
Study Locations (12)
Other
- STENUM Ortho Fachklinik - Ganderkesee
- Wirbelsäulenzentrum Fulda | Main | Kinzig - Gelnhausen
- Katholisches Klinikum Koblenz - Montabaur - Koblenz
- St. Christopherus Krankenhaus - Katholisches Klinikum - Werne
- Hospital Nacional de Parapléjicos - Toledo
Florida
- Florida Back Institute - Boca Raton
- Spine Institute of South Florida - Delray Beach
Indiana
- Indiana Spine Group - Carmel
- DK Orthopedics - Crown Point
Connecticut
- Hartford Hospital - Hartford
Illinois
- Suburban Orthopaedics - Bartlett
Ohio
- Lindner Center for Research & Education at The Christ Hospit - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2020-01-28 |
| Est. Completion | 2025-06 |
What NCT04176562 shows while recruiting
NCT04176562 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 220-participant average among 19 other Spinal Fusion trials with a reported enrollment target (2173% higher).
The record links to 10 conditions, with Spinal Fusion appearing as the primary indexed condition, and to 1 intervention - of which RTI Spine products is the first listed.
NCT04176562 lists 12 locations in 6 states (Other, Florida, Indiana).
Frequently Asked Questions
What is clinical trial NCT04176562 about?
NCT04176562 is a clinical study titled "Prospective SPINE Registry". This study is a prospective, multi-center, open label registry designed to collect real-world data on performance and safety data on RTI's spine products.
What is the current status of trial NCT04176562?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2020-01-28. Estimated completion is 2025-06.
What conditions does trial NCT04176562 study?
This clinical trial studies the following conditions: Spinal Fusion, Spinal Stenosis, Musculoskeletal Diseases, Joint Diseases, Sacroiliac; Fusion.
What interventions are being tested in trial NCT04176562?
The interventions under investigation include: RTI Spine products (DEVICE).
Who is sponsoring clinical trial NCT04176562?
This trial is sponsored by Xtant Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04176562 being conducted?
This trial has 12 study locations across Connecticut, Florida, Illinois, Indiana, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Fusion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04176562's enrollment target sits among peer trials
5,000 1st of 19 higher than 19 of 19 other Spinal Fusion trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Fusion trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
RECRUITING · Phase 3
-
Pulse-Width Modulation
RECRUITING · NA
-
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
RECRUITING · Phase 2
-
Durability of Suppl. Rod Constructs-SuppleMentAry Rod Technique for Long-segment Posterior Instrumented Spinal Fusions
RECRUITING
-
Photobiomodulation for Lower Back Pain Post Spinal Fusion and Decompression Surgery
RECRUITING · NA
-
Kids With Iron Deficiency and Scoliosis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI